ARCHIVES

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

BMS Award Honors Jordan; Matthews Media Wins $23 Million Contract From MCI.

April 6, 2001

VTP Implementing 95% Of Ad Hoc Panel Suggestions

May 10, 1985

NSABP Donates Sculpture to NIH to Commemorate 50th Year.

September 19, 2008

International Cancer Genome Consortium Aims To Produce Data On 50 Cancer Types.

May 2, 2008

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

New Algorithm Completes Scan Three Times Faster Than Before

November 25, 2011